Mumbai, March 18 -- Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Apalutamide Tablets, 60 mg (Erleada(R) Tablets, 60 mg).

Published by HT Digital Content Services with permission from Capital Market....